Quest Diagnostics (DGX) Minority Interest (2009 - 2026)

Quest Diagnostics has disclosed Minority Interest across 18 years of filings, most recently posting $300.0 million for Q1 2026.

• Minority Interest for Q1 2026 came in at $300.0 million, up 809.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $300.0 million (up 809.09% YoY), and the FY2025 annual result was $36.0 million, up 2.86% from the prior year.
• Minority Interest came in at $300.0 million for Q1 2026 at Quest Diagnostics, up from $36.0 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $300.0 million in Q1 2026 to a low of $33.0 million in Q1 2025.
• The 5-year median for Minority Interest is $76.0 million (2023), against an average of $71.5 million.
• Across the five-year window, Minority Interest tumbled 57.14% in 2025 and surged 809.09% in 2026, its largest moves.
• Quest Diagnostics' Minority Interest stood at $77.0 million in 2022, then slipped by 1.3% to $76.0 million in 2023, then slumped by 53.95% to $35.0 million in 2024, then advanced by 2.86% to $36.0 million in 2025, then surged by 733.33% to $300.0 million in 2026.
• The last three Minority Interest figures came in at $300.0 million (Q1 2026), $36.0 million (Q4 2025), and $81.0 million (Q3 2025), per Business Quant data.